GCM
GOSS icon

Graham Capital Management’s Gossamer Bio GOSS Stock Holding History

Graham Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,467
Closed -$113K – 1309
2025
Q4 		$113K Sell
36,467
-30,900
-46% -$88.2K ﹤0.01% 1129
2025
Q3 		$177K Buy
67,367
+20,473
+44% +$45.1K ﹤0.01% 1085
2025
Q2 		$57.7K Buy
46,894
+17,917
+62% +$19.5K ﹤0.01% 1238
2025
Q1 		$31.9K Sell
28,977
-5,970
-17% -$6.9K ﹤0.01% 1244
2024
Q4 		$31.6K Buy
+34,947
New +$29.9K ﹤0.01% 1196
2024
Q3 		– Sell
-10,484
Closed -$9.45K – 1186
2024
Q2 		$9.45K Sell
10,484
-8,638
-45% -$6.46K ﹤0.01% 1002
2024
Q1 		$22.6K Buy
+19,122
New +$21K ﹤0.01% 1025
2022
Q4 		– Sell
-150,656
Closed -$1.8M – 1142
2022
Q3 		$1.8M Buy
+150,656
New +$1.87M 0.07% 258

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Graham Capital Management's GOSS Position: Q1 2026 in Review

Graham Capital Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 36,467 shares — an estimated $113K sold.

Graham Capital Management first reported a position in GOSS in Q3 2022 and held it in 8 quarters. The position peaked at $1.8M in Q3 2022. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Graham Capital Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 36,467 Gossamer Bio shares in Q1 2026, an estimated $113K.
  • Graham Capital Management first reported a position in Gossamer Bio in Q3 2022 and held it in 8 quarters.
  • Graham Capital Management's Gossamer Bio position peaked at $1.8M in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.